1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1.
Markets Covered
1.2.2.
Years Considered for
Study
1.2.3.
Key Market
Segmentations
2.
Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and
Trends
4.
Voice of Customer
5.
Global Interventional
Oncology Devices Market Outlook
5.1. Market Size & Forecast
5.1.1.
By Value
5.2. Market Share & Forecast
5.2.1.
By Product (Embolization Devices, Ablation Devices,
Support Devices)
5.2.2.
By Procedure (Thermal Tumor Ablation, Non-thermal Tumor
Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter
Arterial Radioembolization (TARE), Transcatheter Arterial Embolization (TAE))
5.2.3.
By Cancer Type (Liver, Kidney, Lung, Bone, Others)
5.2.4.
By Company (2023)
5.2.5. By
Region
5.3. Market Map
6.
North America Interventional
Oncology Devices Market Outlook
6.1. Market Size & Forecast
6.1.1.
By Value
6.2. Market Share & Forecast
6.2.1.
By Product
6.2.2.
By Procedure
6.2.3.
By Cancer Type
6.2.4.
By Country
6.3. North America: Country Analysis
6.3.1.
United States Interventional
Oncology Devices Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Product
6.3.1.2.2.
By Procedure
6.3.1.2.3.
By Cancer Type
6.3.2.
Mexico Interventional
Oncology Devices Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Product
6.3.2.2.2.
By Procedure
6.3.2.2.3.
By Cancer Type
6.3.3.
Canada Interventional
Oncology Devices Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Product
6.3.3.2.2.
By Procedure
6.3.3.2.3.
By Cancer Type
7.
Europe Interventional
Oncology Devices Market Outlook
7.1. Market Size & Forecast
7.1.1.
By Value
7.2. Market Share & Forecast
7.2.1.
By Product
7.2.2.
By Procedure
7.2.3.
By Cancer Type
7.2.4.
By Country
7.3. Europe: Country Analysis
7.3.1.
France Interventional
Oncology Devices Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product
7.3.1.2.2.
By Procedure
7.3.1.2.3.
By Cancer Type
7.3.2.
Germany Interventional
Oncology Devices Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product
7.3.2.2.2.
By Procedure
7.3.2.2.3.
By Cancer Type
7.3.3.
United Kingdom Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Product
7.3.3.2.2.
By Procedure
7.3.3.2.3.
By Cancer Type
7.3.4.
Italy Interventional
Oncology Devices Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Product
7.3.4.2.2.
By Procedure
7.3.4.2.3.
By Cancer Type
7.3.5.
Spain Interventional
Oncology Devices Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Product
7.3.5.2.2.
By Procedure
7.3.5.2.3.
By Cancer Type
8.
Asia-Pacific Interventional
Oncology Devices Market Outlook
8.1. Market Size & Forecast
8.1.1.
By Value
8.2. Market Share & Forecast
8.2.1.
By Product
8.2.2.
By Procedure
8.2.3.
By Cancer Type
8.2.4.
By Country
8.3. Asia-Pacific: Country Analysis
8.3.1.
China Interventional
Oncology Devices Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product
8.3.1.2.2.
By Procedure
8.3.1.2.3.
By Cancer Type
8.3.2.
India Interventional
Oncology Devices Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product
8.3.2.2.2.
By Procedure
8.3.2.2.3.
By Cancer Type
8.3.3.
South Korea Interventional
Oncology Devices Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product
8.3.3.2.2.
By Procedure
8.3.3.2.3.
By Cancer Type
8.3.4.
Japan Interventional
Oncology Devices Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Product
8.3.4.2.2.
By Procedure
8.3.4.2.3.
By Cancer Type
8.3.5.
Australia Interventional
Oncology Devices Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Product
8.3.5.2.2.
By Procedure
8.3.5.2.3.
By Cancer Type
9.
South America Interventional
Oncology Devices Market Outlook
9.1. Market Size & Forecast
9.1.1.
By Value
9.2. Market Share & Forecast
9.2.1.
By Product
9.2.2.
By Procedure
9.2.3.
By Cancer Type
9.2.4.
By Country
9.3. South America: Country Analysis
9.3.1.
Brazil Interventional
Oncology Devices Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product
9.3.1.2.2.
By Procedure
9.3.1.2.3.
By Cancer Type
9.3.2.
Argentina Interventional
Oncology Devices Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product
9.3.2.2.2.
By Procedure
9.3.2.2.3.
By Cancer Type
9.3.3.
Colombia Interventional
Oncology Devices Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product
9.3.3.2.2.
By Procedure
9.3.3.2.3.
By Cancer Type
10.
Middle East and
Africa Interventional Oncology Devices Market Outlook
10.1.
Market Size &
Forecast
10.1.1. By Value
10.2.
Market Share &
Forecast
10.2.1.
By Product
10.2.2.
By Procedure
10.2.3.
By Cancer Type
10.2.4. By Country
10.3.
MEA: Country
Analysis
10.3.1. South Africa Interventional Oncology Devices
Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Product
10.3.1.2.2.
By Procedure
10.3.1.2.3.
By Cancer Type
10.3.2. Saudi Arabia Interventional Oncology Devices
Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Product
10.3.2.2.2.
By Procedure
10.3.2.2.3.
By Cancer Type
10.3.3. UAE Interventional Oncology Devices
Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Product
10.3.3.2.2.
By Procedure
10.3.3.2.3.
By Cancer Type
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends & Developments
12.1.
Merger &
Acquisition (If Any)
12.2.
Product Launches (If
Any)
12.3.
Recent Developments
13. Porters Five Forces Analysis
13.1.
Competition in the
Industry
13.2.
Potential of New
Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute
Products
14. Competitive Landscape
14.1.
Medtronic PLC
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2.
Terumo Corporation
14.3.
Boston Scientific
Corporation
14.4.
Merit Medical
Systems, Inc.
14.5.
HealthTronics, Inc.
14.6.
Johnson &
Johnson
14.7.
Teleflex Inc.
14.8.
Angiodynamics Inc.
14.9.
MedWaves, Inc.
14.10.
Becton, Dickinson,
and Company
15. Strategic Recommendations
16. About Us & Disclaimer